Göran Wallin - Academia.edu (original) (raw)

Papers by Göran Wallin

Research paper thumbnail of Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes

BMC Endocrine Disorders, Dec 1, 2019

Background: Abscess in the thyroid gland is a rare but severe infectious disease. The condition c... more Background: Abscess in the thyroid gland is a rare but severe infectious disease. The condition can have anatomic or iatrogenic underlying causes. If untreated it could be fatal. Pathogens vary considerably. Treatment is intravenous antibiotics, drainage, and sometimes surgery. Methods: The electronic medical records of all adult patients with acute thyroiditis 2003-2017 treated at the Karolinska University Hospital (catchment area 2 million) in Sweden were systematically reviewed. Results: Five patients were found in the catchment area. One patient from another region but known to us was also included. Thus, six patients (aged 28-73 years) were included in the study. Median length of hospital stay was 7.5 days (4-79 days). All were treated with antibiotics (intravenous n = 5, oral n = 1). Total antibiotic treatment duration was 13.5 days (10-41 days). Blood cultures were positive in three (streptococcus pneumonia, streptococci sanguineous, pepto streptococci), deep tissue culture in three (Escherichia coli, Candida, Hemophilic influenza) and no positive culture at all in two. Drainage was used in three patients. All patients recovered without recurrences. Surgery was performed twice in the acute phase in one. There was no recurrence during 7 years (3-12) of follow-up, but one patient died after three years (severe heart failure and pneumonia). Conclusion: Thyroid abscess in adults is extremely rare nowadays in the developed world. With prompt antibiotic therapy, drainage and in some cases thyroidectomy the prognosis seems favourable.

Research paper thumbnail of Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group

Journal of Clinical Endocrinology & Metabolism, 1996

Research paper thumbnail of Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer

PubMed, Dec 1, 1992

Background: The purpose of this study was to prospectively assess whether nuclear DNA content add... more Background: The purpose of this study was to prospectively assess whether nuclear DNA content added prognostic value to existing risk factors in patients with papillary thyroid cancer. Methods: Nuclear DNA content was measured both on the fine needle aspiration material and the surgical specimen in 73 patients with primary or recurrent papillary thyroid cancer. We modified the existing age of patient, presence of distant metastases, extent and size of the tumor (AMES) risk-group classification to include DNA ploidy with AMES (DAMES). Patients with euploid tumors that were AMES low risk were considered to be DAMES low risk; patients with euploid tumors that were AMES high risk became intermediate risk, and patients with aneuploid tumors that were AMES high risk became DAMES high risk. Results: Forty-eight patients were in the DAMES low-risk group. Recurrences and/or distant metastases developed in only four (8%) of these patients. Twenty-two patients were in the DAMES intermediate-risk group. Twelve (55%) of the intermediate-risk group had residual, recurrent, or distant metastatic disease, with one death from cancer at 120 months. Three patients were in the DAMES high-risk group. Distant metastases developed in all three patients, who died within 24 months from thyroid cancer. A statistically significant difference existed in the development of recurrence/metastases or death from cancer in the DAMES high-risk group compared with the other risk groups combined. Conclusions: Nuclear DNA content adds prognostic value to the existing AMES risk-group classification. Because DNA analysis on fine needle aspiration correlated well with the surgical specimen DNA analysis, this modified classification can be used perioperatively to further individualize the treatment of patients with papillary thyroid cancer.

Research paper thumbnail of Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma

International Journal of Colorectal Disease, Jul 1, 1993

Research paper thumbnail of Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells

PubMed, Aug 1, 1992

The nuclear DNA content in thyroid tumor cells has been shown to be closely related to the malign... more The nuclear DNA content in thyroid tumor cells has been shown to be closely related to the malignant potential of the neoplasm. Besides DNA, nuclear protein (NP) constitutes the major mass of the nucleus. The NP content may vary significantly in relation to the proliferative stage in growing as compared to growth-arrested cells. The increase in NP content associated with the transition from G0 to G1 occurs before the onset of DNA synthesis and may be used to assess growth activity. The nuclear DNA and NP contents were analyzed in 90 nonneoplastic lesions and 75 benign and 62 malignant thyroid tumors. All nonneoplastic specimens were euploid, and 1 of 90 was growth activated. In the group of benign tumors, 59 were euploid, and 16 were aneuploid. Among these there were 5 (9%) of 59 and 6 (38%) of 16 growth-activated specimens, respectively. In the group of malignant tumors 57 of 62 were classified as euploid, and in this group 12 (21%) showed growth activity according to the NP content. Five of 62 were aneuploid, and 3 (60%) of these 5 tumors were growth activated. Evaluation of the growth activity by means of monoclonal antibody Ki-67 was performed on a subgroup of 32 thyroid specimens, both nonneoplastic and neoplastic lesions. Ki-67 immunoreactivity was observed in 0-1.1% cells of 6 nonneoplastic lesions, in 0-3.1% cells of 14 benign cells and in 0.2-3.9% cells of 12 malignant thyroid tumors. Growth activity, as reflected by the NP/DNA ratio and Ki-67 immunoreactivity, appears to be low both in nonneoplastic thyroid lesions and thyroid tumors.

Research paper thumbnail of Peritoneal Bridging Versus Nonclosure in Laparoscopic Ventral Hernia Repair

Annals of surgery open, Feb 2, 2023

Introduction: Postoperative seroma and pain are common problems following laparoscopic intraperit... more Introduction: Postoperative seroma and pain are common problems following laparoscopic intraperitoneal onlay mesh (IPOM) repair of ventral hernias. These adverse outcomes may be avoided by dissecting and using the peritoneum in the hernial sac to bridge the hernia defect. Methods: This was a patient- and outcome assessor-blinded, parallel-design, randomized controlled trial comparing nonclosure and peritoneal bridging approaches in patients scheduled for elective midline ventral hernia repair. The primary endpoint was seroma volume on ultrasonography. The secondary endpoints were postoperative pain, recurrence, and complications. Results: Between November 2018 and December 2020, 112 patients were randomized, of whom 60 were in the nonclosure group and 52 were in the peritoneal bridging group. The seroma volume in the nonclosure and peritoneal bridging groups were 17 cm3 (6–53 cm3) versus 0 cm3 (0–26 cm3) at 1-month follow-up (P = 0.013). The median volume was zero at the 3-, 6-, and 12-month follow-ups in both groups. No significant differences were observed in early postoperative pain (P = 0.447) and in recurrence rate (P = 0.684). There were 4 (7%) and 1 (2%) perioperative complications that lead to reoperations in simple IPOM (sIPOM) and IPOM with peritoneal bridging (IPOM-pb), respectively. Conclusions: Seroma was less prevalent after IPOM-pb at 1-month follow-up compared with sIPOM, with similar postoperative pain 1 week after index surgery in both groups. At subsequent follow-ups, the differences in seroma were not statistically significant. Further studies are required to confirm these results. Trial registration (NCT04229940).

Research paper thumbnail of Operation for Primary Hyperparathyroidism: The New versus the Old Order

Scandinavian Journal of Surgery, Mar 1, 2007

Background and Aims: in patients with primary hyperparathyroidism (phpt), parathyroid imaging is ... more Background and Aims: in patients with primary hyperparathyroidism (phpt), parathyroid imaging is nowadays routinely used for the purpose to perform af ocused unilateral minimally invasive operation. the outcome of this new strategy has, however,not been established in randomised trials. Material and Methods: patients were randomised to either preoperativel ocalisation with sestamibi scintigraphyand ultrasonography (group i) or no preoperativelocalisation (group ii). in group i, am inimally invasive parathyroidectomy was performed in patients in whom both localisation studies were consistent with as ingle pathological gland, whereas ac onventional bilateral neck exploration was performed in casesw ith negative localisation findings. In group II all patients underwent conventional bilateral neck exploration. primary outcome measure was normocalcaemia at 6m onths postoperatively. Results: in the preoperative localisation group (group i) 23/50 (46%) of the patients could be operatedonwith the focused operation whereas 26/50 (52%) were operated on by bilateral neck exploration. all patients in the no localisation group (group ii; n=50) were operated on with the intended bilateral neck operation. normocalcaemia was obtained in 96% and 94% in group iand ii, respectively.t otal (localisation and operative) costs were 21% higheringroup i. Conclusions: routinep reoperative localisation,w ith the intention to perform minimally invasive parathyroidectomy,isnot cost effective if concordant results of scintigraphy and ultrasonography are aprerequisite for the focused operation. less than half of the patients were successfully managed with this strategy,atahigher cost and without obtaining amore favourable clinical outcome.

Research paper thumbnail of BJS-02 Long-Term Reoperation Rate Following Primary Ventral Hernia Repair: A Register-Based Study

British Journal of Surgery, Oct 1, 2022

Aim The aim of this study was to analyse the risk for reoperation following primary ventral herni... more Aim The aim of this study was to analyse the risk for reoperation following primary ventral hernia repair. Methods The study was based on umbilical hernia and epigastric hernia repairs registered in the population-based Swedish National Patient Register (NPR) 2010–2019. Reoperation was defined as repeat repair after primary repair. Results Altogether 30,253 umbilical hernia repairs and 7407 epigastric hernia repairs were identified. There were 624 reoperations registered following primary umbilical repair and 137 following primary epigastric repairs. In multivariable Cox proportional hazard analysis, the hazard ratio (HR) for reoperation was 0.284 (95% confidence interval (CI) 0.106–0.760) after open onlay mesh repair, 0.476 (CI 0.359–0.629) after open interstitial mesh repair, 0.368 (CI 0.230–0.590) after open sublay mesh repair, 0.446 (CI 0.167–1.194) after open intraperitoneal onlay mesh repair, 0.931 (CI 0.639–1.357) after laparoscopic repair, and 0.939 (CI 0.502–1.757) after other (unknown) techniques, when compared to open suture repair as reference method. Following umbilical hernia repair, the risk for reoperation was also significantly higher for patients aged ≤49 years (HR 1.669, CI 1.391–2.002), for women (HR 1.390, CI 1.178–1.641), and for patients with liver cirrhosis (HR 2.546, CI 1.050–6.174). For patients undergoing epigastric hernia repair, the only significant risk factor for reoperation was age ≤49 years (HR 2.079, CI 1.380–3.134). Conclusions All types of open mesh repair were associated with lower reoperation rates than open suture repair and laparoscopic repair. Female sex, young age and liver cirrhosis were risk factors for reoperation due to hernia recurrence, regardless of method.

Research paper thumbnail of Nuclear DNA measurements in follicular thyroid adenomas

PubMed, Apr 1, 1989

The nuclear DNA content was measured retrospectively in histologically confirmed follicular adeno... more The nuclear DNA content was measured retrospectively in histologically confirmed follicular adenomas in 20 patients, and prospectively in 25 patients. In the retrospective group two of the adenomas, and in the prospective group three of the adenomas were classified as atypical due to high cellularity and nuclear atypia, but with no sign of micro-invasive growth. In the group of patients studied retrospectively, the two patients with atypical adenoma had an aneuploid DNA pattern. One of these died 11 years after diagnosis with generalized disease. The other patient in this group with an aneuploid atypical adenoma is alive, as are all the remaining 18 patients with diploid adenomas. In the prospective group there were five aneuploid tumours. The atypical adenomas were aneuploid in two cases and polyploid in one case. No patient in the prospective group has shown any evidence of recurrence so far. Although DNA measurements are of value in distinguishing between low and high malignant potential in invasive tumors, the prognostic information if no invasion is found is uncertain. The importance of examining an adequate number of tissue blocks from the capsular region is emphasized.

Research paper thumbnail of Oncogene and growth factor expression in MEN 2 and related tumors

PubMed, 1992

Pheochromocytomas occur sporadically or in individuals affected by inherited syndromes including ... more Pheochromocytomas occur sporadically or in individuals affected by inherited syndromes including multiple endocrine neoplasia (MEN) type 2A and 2B, neurofibromatosis, and the von Hippel-Lindau syndrome (vHL). Medullary thyroid carcinomas (MTCs) also occur sporadically or as part of MEN 2A, MEN 2B, and familial MTC. Little is known of the molecular genetic background of these tumors. We have shown previously that activation of the N-ras, H-ras, and K-ras oncogenes does not occur in these tumors, but that deletions of the short arm of chromosome 1 are extremely common (> 60%) and may indicate loss of a suppressor gene in the chromosomal region 1p31-36. We have examined the structure and expression of N-myc, c-myc, L-myc, c-mos, nerve growth factor (beta-NGF), and the low affinity nerve growth factor receptor (LNGFR) in a series of pheochromocytomas and MTCs from patients with hereditary and sporadic diseases. Southern analysis, using radiolabeled DNA probes, revealed no evidence of amplification or rearrangement of these genes in any normal or tumor tissues except for loss of heterozygosity at the L-myc locus (1p32) in 9 pheochromocytomas from patients with MEN 2A or MEN 2B, in 5 of 11 non-MEN pheochromocytomas, and in 3 of 24 non-MEN MTCs. Gene expression at the RNA level was examined by Northern analysis or ribonuclease protection assay (RPA) using radiolabeled DNA or cRNA probes. C-myc transcripts were detectable at low levels in all tumors tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Research paper thumbnail of Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors

International Journal of Oncology, 2005

Proximal-type epithelioid sarcoma is a recently described soft-tissue tumor that is distinguished... more Proximal-type epithelioid sarcoma is a recently described soft-tissue tumor that is distinguished from conventional-type epithelioid sarcoma by a far more aggressive clinical course, frequent location in the proximal anatomic regions, and variable rhabdoid morphology. Because of their rarity and peculiar morphology, proximal-type epithelioid sarcomas frequently pose serious diagnostic dilemmas, being easily misdiagnosed as a variety of other malignant neoplasms. To date, the information available on the genetic alterations associated with this tumor entity has been confined to single conventional cytogenetic reports. In this article, we present the results of a conventional and molecular cytogenetic analysis of six proximal-type epithelioid sarcomas. Spectral karyotyping analysis of these cases deciphered the characteristics of several marker chromosomes and complex translocations, leading to the recognition of recurrent rearrangements. The most frequently involved chromosome arm was 22q, and the identification of two cases with a similar translocation, t(10;22), suggests a role for one or more genes on chromosome 22 in the pathogenesis of this tumor and provides an opportunity for finely mapping the translocation-associated breakpoints. Chromosome arm 8q gain was also a frequent event and correlated with gain of MYC gene copy number, as demonstrated by fluorescence in situ hybridization. A review of both cases reported in the literature and those presented in this study reinforced the involvement of chromosomes 8 and 22 and also indicated frequent rearrangements of chromosomes 7, 14, 18, and 20.

Research paper thumbnail of Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study

PubMed, Feb 1, 1989

Clonal transformation of well differentiated follicular or papillary carcinomas has been suggeste... more Clonal transformation of well differentiated follicular or papillary carcinomas has been suggested as a mechanism by which anaplastic carcinomas of the thyroid might arise. Of 126 cases of anaplastic (giant cell) carcinomas, 17 (13.5%) contained histologically well differentiated tumour foci within or adjacent to the high grade malignant anaplastic tumour. Cytophotometric DNA analysis after Feulgen staining was performed on 11 cases in order to evaluate ploidy of the anaplastic and the well differentiated tumour cells. The majority of these co-existent carcinomas (9/11) were papillary. All 11 anaplastic carcinomas demonstrated an aneuploid DNA pattern which correlated with a poor clinical outcome (7 of 11 died of disease in less than 6 months). In contrast six co-existent papillary and one co-existent follicular tumours were diploid. These data show that the co-existence of anaplastic and well differentiated carcinoma occurs only rarely and when it occurs only one third of the well differentiated tumours contain aneuploid tumour cells. This suggests that in the majority of cases of anaplastic thyroid carcinoma the malignant cells arise de novo rather than through clonal transformation of well differentiated carcinomas.

Research paper thumbnail of Correlating the Bethesda System for Reporting Thyroid Cytopathology with Histology and Extent of Surgery: A Review of 21,746 Patients from Four Endocrine Surgery Registries Across Two Continents

World Journal of Surgery, Nov 5, 2019

Background The Bethesda system for cytopathology (TBSRTC) is a 6-tier diagnostic framework develo... more Background The Bethesda system for cytopathology (TBSRTC) is a 6-tier diagnostic framework developed to standardize thyroid cytopathology reporting. The aim of this study was to determine the risk of malignancy (ROM) for each Bethesda category. Methods Thyroidectomy-related data from 314 facilities in 22 countries were entered into the following outcome registries: CESQIP (North America), Eurocrine (Europe), SQRTPA (Sweden) and UKRETS (UK). Demographic, cytological, pathologic and extent of surgery data were mapped into one dataset and analyzed.

Research paper thumbnail of Anaplastic Giant Cell Thyroid Carcinoma

Scandinavian Journal of Surgery, Dec 1, 2004

Anaplastic (giant cell) thyroid carcinoma (ATC), is one of the most aggressive malignancies in hu... more Anaplastic (giant cell) thyroid carcinoma (ATC), is one of the most aggressive malignancies in humans with a median survival time after diagnosis of 3-6 months. Death from ATC was earlier seen because of local growth and suffocation. ATC is uncommon, accounting for less than 5 % of all thyroid carcinomas. The diagnosis can be established by means of multiple fine needle aspiration biopsies, which are neither harmful nor troublesome for the patient. The cytological diagnosis of this high-grade malignant tumour is usually not difficult for a well trained cytologist. The intention to treat patients with ATC is cure, although only few of them survive. The majority of the patients are older than 60 years and treatment must be influenced by their high age. We have by using a combined modality regimen succeeded in achieving local control in most patients. Every effort should be made to control the primary tumour and thereby improve the quality of remaining life and it is important for patients, relatives and the personnel to know that cure is not impossible. Different treatment combinations have been used since 30 years including radiotherapy, cytostatic drugs and surgery, when feasible. In our latest combined regimen, 22 patients were treated with hyper fractionated radiotherapy 1.6Gy × × × × × 2 to a total target dose of 46 Gy given preoperatively, 20 mg doxorubicin was administered intravenously once weekly and surgery was carried out 2-3 weeks after the radiotherapy. 17 of these 22 patients were operated upon and none of these 17 patients got a local recurrence. In the future we are awaiting the development of new therapeutic approaches to this aggressive type of carcinoma. Inhibitors of angiogenesis might be useful. Combretastatin has displayed cytotoxicity against ATC cell lines and has had a positive effect on ATC in a patient. Sodium iodide symporter (NIS) genetherapy is also being currently considered for dedifferentiated thyroid carcinomas with the ultimate aim of making radioiodine therapy possible.

Research paper thumbnail of Isolation and structural characterization of thymosin-β4 from a human medullary thyroid carcinoma

Journal of Endocrinology, Jul 1, 1988

ABSTRACT An extract of a tumour metastases from a human medullary thyroid carcinoma contained a h... more ABSTRACT An extract of a tumour metastases from a human medullary thyroid carcinoma contained a high concentration (at least 2·9 nmol/g wet weight) of the immunoregulatory peptide, thymosin-β4. The peptide was isolated as a mixture of two components with free and blocked NH2-terminal amino acid residues, the latter form predominating (approximately 98% of the total). The primary structure of the peptide was established by automated Edman degradation after cleavage with cyanogen bromide. The amino acid sequence of human thymosin-β4 was identical to thymosin-β4 previously isolated from calf thymus. Further studies are warranted to determine whether thymosin-β4 production is a useful marker for thyroid and other tumours. J. Endocr. (1988) 118, 155–159

Research paper thumbnail of Tratamiento del cáncer anaplásico de tiroides

Revisiones en cáncer, 2005

Los carcinomas anaplasicos de tiroides (CAT) estan entre los canceres mas agresivos, con una medi... more Los carcinomas anaplasicos de tiroides (CAT) estan entre los canceres mas agresivos, con una mediana de supervivencia de 3-6 meses. Antiguamente, la muerte por CAT solia deberse al crecimiento local y producirse, fundamentalmente, por asifixia. Debe hacerse todo lo posible por controlar el tumor primario, mejorando asi la calidad del resto de la vida. Desde hace 30 anos se han venido usando distintos tratamientos combinados, incluidos la radioterapia, los farmacos citostaticos y la cirugia, en los casos factibles. En nuestro ultimo regimen combinado, 22 pacientes se trataron con radioterapia hiperfraccionada a dosis de 1,6 Gy x 2, hasta una dosis objetivo total de 46 Gy, en el preoperatorio, 20 mg de doxorrubicina administrados por la via intravenosa semanalmente y cirugia a las 2-3 semanas de haber finalizado la radioterapia. Se opero a diecisiete de estos 22 pacientes, no presentando recurrencias locales ninguno de los 17. El reto futuro es el tratamiento de las metastasis a distancia. Se recomiendan los nuevos agentes quimioterapeuticos y las nuevas modalidades, como los inhibidores de la angiogenesis.

Research paper thumbnail of Thyroid and Parathyroid Carcinoma

Springer eBooks, 1989

Malignant neoplasms of the thyroid are rare and account for about 1% of all cancers. About 90% of... more Malignant neoplasms of the thyroid are rare and account for about 1% of all cancers. About 90% of the thyroid malignancies are differentiated carcinomas including papillary, follicular and medullary tumours. Differentiated thyroid carcinomas often appear in young individuals and have a peak incidence in the third or fourth decade. In contrast, the anaplastic thyroid carcinoma is largely a disease of the elderly.

Research paper thumbnail of Dual energy 4D-CT of parathyroid adenomas not clearly localized by sestamibi scintigraphy and ultrasonography – a retrospective study

European Journal of Radiology, Mar 1, 2020

This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Research paper thumbnail of Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas

European journal of endocrinology, Jun 1, 2000

Research paper thumbnail of Effect of the SARS-CoV-2 pandemic on planned and emergency hernia repair in Sweden: a register-based study

Hernia, Jul 7, 2023

Purpose The COVID-19 has had a profound impact on the health care delivery in Sweden, including d... more Purpose The COVID-19 has had a profound impact on the health care delivery in Sweden, including deprioritization of benign surgeries during the COVID-19 pandemic. The aim of this study was to assess the effect of COVID-19 pandemic on emergency and planned hernia repair in Sweden.

Research paper thumbnail of Acute suppurative thyroiditis with thyroid abscess in adults: clinical presentation, treatment and outcomes

BMC Endocrine Disorders, Dec 1, 2019

Background: Abscess in the thyroid gland is a rare but severe infectious disease. The condition c... more Background: Abscess in the thyroid gland is a rare but severe infectious disease. The condition can have anatomic or iatrogenic underlying causes. If untreated it could be fatal. Pathogens vary considerably. Treatment is intravenous antibiotics, drainage, and sometimes surgery. Methods: The electronic medical records of all adult patients with acute thyroiditis 2003-2017 treated at the Karolinska University Hospital (catchment area 2 million) in Sweden were systematically reviewed. Results: Five patients were found in the catchment area. One patient from another region but known to us was also included. Thus, six patients (aged 28-73 years) were included in the study. Median length of hospital stay was 7.5 days (4-79 days). All were treated with antibiotics (intravenous n = 5, oral n = 1). Total antibiotic treatment duration was 13.5 days (10-41 days). Blood cultures were positive in three (streptococcus pneumonia, streptococci sanguineous, pepto streptococci), deep tissue culture in three (Escherichia coli, Candida, Hemophilic influenza) and no positive culture at all in two. Drainage was used in three patients. All patients recovered without recurrences. Surgery was performed twice in the acute phase in one. There was no recurrence during 7 years (3-12) of follow-up, but one patient died after three years (severe heart failure and pneumonia). Conclusion: Thyroid abscess in adults is extremely rare nowadays in the developed world. With prompt antibiotic therapy, drainage and in some cases thyroidectomy the prognosis seems favourable.

Research paper thumbnail of Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group

Journal of Clinical Endocrinology & Metabolism, 1996

Research paper thumbnail of Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer

PubMed, Dec 1, 1992

Background: The purpose of this study was to prospectively assess whether nuclear DNA content add... more Background: The purpose of this study was to prospectively assess whether nuclear DNA content added prognostic value to existing risk factors in patients with papillary thyroid cancer. Methods: Nuclear DNA content was measured both on the fine needle aspiration material and the surgical specimen in 73 patients with primary or recurrent papillary thyroid cancer. We modified the existing age of patient, presence of distant metastases, extent and size of the tumor (AMES) risk-group classification to include DNA ploidy with AMES (DAMES). Patients with euploid tumors that were AMES low risk were considered to be DAMES low risk; patients with euploid tumors that were AMES high risk became intermediate risk, and patients with aneuploid tumors that were AMES high risk became DAMES high risk. Results: Forty-eight patients were in the DAMES low-risk group. Recurrences and/or distant metastases developed in only four (8%) of these patients. Twenty-two patients were in the DAMES intermediate-risk group. Twelve (55%) of the intermediate-risk group had residual, recurrent, or distant metastatic disease, with one death from cancer at 120 months. Three patients were in the DAMES high-risk group. Distant metastases developed in all three patients, who died within 24 months from thyroid cancer. A statistically significant difference existed in the development of recurrence/metastases or death from cancer in the DAMES high-risk group compared with the other risk groups combined. Conclusions: Nuclear DNA content adds prognostic value to the existing AMES risk-group classification. Because DNA analysis on fine needle aspiration correlated well with the surgical specimen DNA analysis, this modified classification can be used perioperatively to further individualize the treatment of patients with papillary thyroid cancer.

Research paper thumbnail of Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermoid carcinoma

International Journal of Colorectal Disease, Jul 1, 1993

Research paper thumbnail of Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells

PubMed, Aug 1, 1992

The nuclear DNA content in thyroid tumor cells has been shown to be closely related to the malign... more The nuclear DNA content in thyroid tumor cells has been shown to be closely related to the malignant potential of the neoplasm. Besides DNA, nuclear protein (NP) constitutes the major mass of the nucleus. The NP content may vary significantly in relation to the proliferative stage in growing as compared to growth-arrested cells. The increase in NP content associated with the transition from G0 to G1 occurs before the onset of DNA synthesis and may be used to assess growth activity. The nuclear DNA and NP contents were analyzed in 90 nonneoplastic lesions and 75 benign and 62 malignant thyroid tumors. All nonneoplastic specimens were euploid, and 1 of 90 was growth activated. In the group of benign tumors, 59 were euploid, and 16 were aneuploid. Among these there were 5 (9%) of 59 and 6 (38%) of 16 growth-activated specimens, respectively. In the group of malignant tumors 57 of 62 were classified as euploid, and in this group 12 (21%) showed growth activity according to the NP content. Five of 62 were aneuploid, and 3 (60%) of these 5 tumors were growth activated. Evaluation of the growth activity by means of monoclonal antibody Ki-67 was performed on a subgroup of 32 thyroid specimens, both nonneoplastic and neoplastic lesions. Ki-67 immunoreactivity was observed in 0-1.1% cells of 6 nonneoplastic lesions, in 0-3.1% cells of 14 benign cells and in 0.2-3.9% cells of 12 malignant thyroid tumors. Growth activity, as reflected by the NP/DNA ratio and Ki-67 immunoreactivity, appears to be low both in nonneoplastic thyroid lesions and thyroid tumors.

Research paper thumbnail of Peritoneal Bridging Versus Nonclosure in Laparoscopic Ventral Hernia Repair

Annals of surgery open, Feb 2, 2023

Introduction: Postoperative seroma and pain are common problems following laparoscopic intraperit... more Introduction: Postoperative seroma and pain are common problems following laparoscopic intraperitoneal onlay mesh (IPOM) repair of ventral hernias. These adverse outcomes may be avoided by dissecting and using the peritoneum in the hernial sac to bridge the hernia defect. Methods: This was a patient- and outcome assessor-blinded, parallel-design, randomized controlled trial comparing nonclosure and peritoneal bridging approaches in patients scheduled for elective midline ventral hernia repair. The primary endpoint was seroma volume on ultrasonography. The secondary endpoints were postoperative pain, recurrence, and complications. Results: Between November 2018 and December 2020, 112 patients were randomized, of whom 60 were in the nonclosure group and 52 were in the peritoneal bridging group. The seroma volume in the nonclosure and peritoneal bridging groups were 17 cm3 (6–53 cm3) versus 0 cm3 (0–26 cm3) at 1-month follow-up (P = 0.013). The median volume was zero at the 3-, 6-, and 12-month follow-ups in both groups. No significant differences were observed in early postoperative pain (P = 0.447) and in recurrence rate (P = 0.684). There were 4 (7%) and 1 (2%) perioperative complications that lead to reoperations in simple IPOM (sIPOM) and IPOM with peritoneal bridging (IPOM-pb), respectively. Conclusions: Seroma was less prevalent after IPOM-pb at 1-month follow-up compared with sIPOM, with similar postoperative pain 1 week after index surgery in both groups. At subsequent follow-ups, the differences in seroma were not statistically significant. Further studies are required to confirm these results. Trial registration (NCT04229940).

Research paper thumbnail of Operation for Primary Hyperparathyroidism: The New versus the Old Order

Scandinavian Journal of Surgery, Mar 1, 2007

Background and Aims: in patients with primary hyperparathyroidism (phpt), parathyroid imaging is ... more Background and Aims: in patients with primary hyperparathyroidism (phpt), parathyroid imaging is nowadays routinely used for the purpose to perform af ocused unilateral minimally invasive operation. the outcome of this new strategy has, however,not been established in randomised trials. Material and Methods: patients were randomised to either preoperativel ocalisation with sestamibi scintigraphyand ultrasonography (group i) or no preoperativelocalisation (group ii). in group i, am inimally invasive parathyroidectomy was performed in patients in whom both localisation studies were consistent with as ingle pathological gland, whereas ac onventional bilateral neck exploration was performed in casesw ith negative localisation findings. In group II all patients underwent conventional bilateral neck exploration. primary outcome measure was normocalcaemia at 6m onths postoperatively. Results: in the preoperative localisation group (group i) 23/50 (46%) of the patients could be operatedonwith the focused operation whereas 26/50 (52%) were operated on by bilateral neck exploration. all patients in the no localisation group (group ii; n=50) were operated on with the intended bilateral neck operation. normocalcaemia was obtained in 96% and 94% in group iand ii, respectively.t otal (localisation and operative) costs were 21% higheringroup i. Conclusions: routinep reoperative localisation,w ith the intention to perform minimally invasive parathyroidectomy,isnot cost effective if concordant results of scintigraphy and ultrasonography are aprerequisite for the focused operation. less than half of the patients were successfully managed with this strategy,atahigher cost and without obtaining amore favourable clinical outcome.

Research paper thumbnail of BJS-02 Long-Term Reoperation Rate Following Primary Ventral Hernia Repair: A Register-Based Study

British Journal of Surgery, Oct 1, 2022

Aim The aim of this study was to analyse the risk for reoperation following primary ventral herni... more Aim The aim of this study was to analyse the risk for reoperation following primary ventral hernia repair. Methods The study was based on umbilical hernia and epigastric hernia repairs registered in the population-based Swedish National Patient Register (NPR) 2010–2019. Reoperation was defined as repeat repair after primary repair. Results Altogether 30,253 umbilical hernia repairs and 7407 epigastric hernia repairs were identified. There were 624 reoperations registered following primary umbilical repair and 137 following primary epigastric repairs. In multivariable Cox proportional hazard analysis, the hazard ratio (HR) for reoperation was 0.284 (95% confidence interval (CI) 0.106–0.760) after open onlay mesh repair, 0.476 (CI 0.359–0.629) after open interstitial mesh repair, 0.368 (CI 0.230–0.590) after open sublay mesh repair, 0.446 (CI 0.167–1.194) after open intraperitoneal onlay mesh repair, 0.931 (CI 0.639–1.357) after laparoscopic repair, and 0.939 (CI 0.502–1.757) after other (unknown) techniques, when compared to open suture repair as reference method. Following umbilical hernia repair, the risk for reoperation was also significantly higher for patients aged ≤49 years (HR 1.669, CI 1.391–2.002), for women (HR 1.390, CI 1.178–1.641), and for patients with liver cirrhosis (HR 2.546, CI 1.050–6.174). For patients undergoing epigastric hernia repair, the only significant risk factor for reoperation was age ≤49 years (HR 2.079, CI 1.380–3.134). Conclusions All types of open mesh repair were associated with lower reoperation rates than open suture repair and laparoscopic repair. Female sex, young age and liver cirrhosis were risk factors for reoperation due to hernia recurrence, regardless of method.

Research paper thumbnail of Nuclear DNA measurements in follicular thyroid adenomas

PubMed, Apr 1, 1989

The nuclear DNA content was measured retrospectively in histologically confirmed follicular adeno... more The nuclear DNA content was measured retrospectively in histologically confirmed follicular adenomas in 20 patients, and prospectively in 25 patients. In the retrospective group two of the adenomas, and in the prospective group three of the adenomas were classified as atypical due to high cellularity and nuclear atypia, but with no sign of micro-invasive growth. In the group of patients studied retrospectively, the two patients with atypical adenoma had an aneuploid DNA pattern. One of these died 11 years after diagnosis with generalized disease. The other patient in this group with an aneuploid atypical adenoma is alive, as are all the remaining 18 patients with diploid adenomas. In the prospective group there were five aneuploid tumours. The atypical adenomas were aneuploid in two cases and polyploid in one case. No patient in the prospective group has shown any evidence of recurrence so far. Although DNA measurements are of value in distinguishing between low and high malignant potential in invasive tumors, the prognostic information if no invasion is found is uncertain. The importance of examining an adequate number of tissue blocks from the capsular region is emphasized.

Research paper thumbnail of Oncogene and growth factor expression in MEN 2 and related tumors

PubMed, 1992

Pheochromocytomas occur sporadically or in individuals affected by inherited syndromes including ... more Pheochromocytomas occur sporadically or in individuals affected by inherited syndromes including multiple endocrine neoplasia (MEN) type 2A and 2B, neurofibromatosis, and the von Hippel-Lindau syndrome (vHL). Medullary thyroid carcinomas (MTCs) also occur sporadically or as part of MEN 2A, MEN 2B, and familial MTC. Little is known of the molecular genetic background of these tumors. We have shown previously that activation of the N-ras, H-ras, and K-ras oncogenes does not occur in these tumors, but that deletions of the short arm of chromosome 1 are extremely common (> 60%) and may indicate loss of a suppressor gene in the chromosomal region 1p31-36. We have examined the structure and expression of N-myc, c-myc, L-myc, c-mos, nerve growth factor (beta-NGF), and the low affinity nerve growth factor receptor (LNGFR) in a series of pheochromocytomas and MTCs from patients with hereditary and sporadic diseases. Southern analysis, using radiolabeled DNA probes, revealed no evidence of amplification or rearrangement of these genes in any normal or tumor tissues except for loss of heterozygosity at the L-myc locus (1p32) in 9 pheochromocytomas from patients with MEN 2A or MEN 2B, in 5 of 11 non-MEN pheochromocytomas, and in 3 of 24 non-MEN MTCs. Gene expression at the RNA level was examined by Northern analysis or ribonuclease protection assay (RPA) using radiolabeled DNA or cRNA probes. C-myc transcripts were detectable at low levels in all tumors tested.(ABSTRACT TRUNCATED AT 250 WORDS)

Research paper thumbnail of Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors

International Journal of Oncology, 2005

Proximal-type epithelioid sarcoma is a recently described soft-tissue tumor that is distinguished... more Proximal-type epithelioid sarcoma is a recently described soft-tissue tumor that is distinguished from conventional-type epithelioid sarcoma by a far more aggressive clinical course, frequent location in the proximal anatomic regions, and variable rhabdoid morphology. Because of their rarity and peculiar morphology, proximal-type epithelioid sarcomas frequently pose serious diagnostic dilemmas, being easily misdiagnosed as a variety of other malignant neoplasms. To date, the information available on the genetic alterations associated with this tumor entity has been confined to single conventional cytogenetic reports. In this article, we present the results of a conventional and molecular cytogenetic analysis of six proximal-type epithelioid sarcomas. Spectral karyotyping analysis of these cases deciphered the characteristics of several marker chromosomes and complex translocations, leading to the recognition of recurrent rearrangements. The most frequently involved chromosome arm was 22q, and the identification of two cases with a similar translocation, t(10;22), suggests a role for one or more genes on chromosome 22 in the pathogenesis of this tumor and provides an opportunity for finely mapping the translocation-associated breakpoints. Chromosome arm 8q gain was also a frequent event and correlated with gain of MYC gene copy number, as demonstrated by fluorescence in situ hybridization. A review of both cases reported in the literature and those presented in this study reinforced the involvement of chromosomes 8 and 22 and also indicated frequent rearrangements of chromosomes 7, 14, 18, and 20.

Research paper thumbnail of Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study

PubMed, Feb 1, 1989

Clonal transformation of well differentiated follicular or papillary carcinomas has been suggeste... more Clonal transformation of well differentiated follicular or papillary carcinomas has been suggested as a mechanism by which anaplastic carcinomas of the thyroid might arise. Of 126 cases of anaplastic (giant cell) carcinomas, 17 (13.5%) contained histologically well differentiated tumour foci within or adjacent to the high grade malignant anaplastic tumour. Cytophotometric DNA analysis after Feulgen staining was performed on 11 cases in order to evaluate ploidy of the anaplastic and the well differentiated tumour cells. The majority of these co-existent carcinomas (9/11) were papillary. All 11 anaplastic carcinomas demonstrated an aneuploid DNA pattern which correlated with a poor clinical outcome (7 of 11 died of disease in less than 6 months). In contrast six co-existent papillary and one co-existent follicular tumours were diploid. These data show that the co-existence of anaplastic and well differentiated carcinoma occurs only rarely and when it occurs only one third of the well differentiated tumours contain aneuploid tumour cells. This suggests that in the majority of cases of anaplastic thyroid carcinoma the malignant cells arise de novo rather than through clonal transformation of well differentiated carcinomas.

Research paper thumbnail of Correlating the Bethesda System for Reporting Thyroid Cytopathology with Histology and Extent of Surgery: A Review of 21,746 Patients from Four Endocrine Surgery Registries Across Two Continents

World Journal of Surgery, Nov 5, 2019

Background The Bethesda system for cytopathology (TBSRTC) is a 6-tier diagnostic framework develo... more Background The Bethesda system for cytopathology (TBSRTC) is a 6-tier diagnostic framework developed to standardize thyroid cytopathology reporting. The aim of this study was to determine the risk of malignancy (ROM) for each Bethesda category. Methods Thyroidectomy-related data from 314 facilities in 22 countries were entered into the following outcome registries: CESQIP (North America), Eurocrine (Europe), SQRTPA (Sweden) and UKRETS (UK). Demographic, cytological, pathologic and extent of surgery data were mapped into one dataset and analyzed.

Research paper thumbnail of Anaplastic Giant Cell Thyroid Carcinoma

Scandinavian Journal of Surgery, Dec 1, 2004

Anaplastic (giant cell) thyroid carcinoma (ATC), is one of the most aggressive malignancies in hu... more Anaplastic (giant cell) thyroid carcinoma (ATC), is one of the most aggressive malignancies in humans with a median survival time after diagnosis of 3-6 months. Death from ATC was earlier seen because of local growth and suffocation. ATC is uncommon, accounting for less than 5 % of all thyroid carcinomas. The diagnosis can be established by means of multiple fine needle aspiration biopsies, which are neither harmful nor troublesome for the patient. The cytological diagnosis of this high-grade malignant tumour is usually not difficult for a well trained cytologist. The intention to treat patients with ATC is cure, although only few of them survive. The majority of the patients are older than 60 years and treatment must be influenced by their high age. We have by using a combined modality regimen succeeded in achieving local control in most patients. Every effort should be made to control the primary tumour and thereby improve the quality of remaining life and it is important for patients, relatives and the personnel to know that cure is not impossible. Different treatment combinations have been used since 30 years including radiotherapy, cytostatic drugs and surgery, when feasible. In our latest combined regimen, 22 patients were treated with hyper fractionated radiotherapy 1.6Gy × × × × × 2 to a total target dose of 46 Gy given preoperatively, 20 mg doxorubicin was administered intravenously once weekly and surgery was carried out 2-3 weeks after the radiotherapy. 17 of these 22 patients were operated upon and none of these 17 patients got a local recurrence. In the future we are awaiting the development of new therapeutic approaches to this aggressive type of carcinoma. Inhibitors of angiogenesis might be useful. Combretastatin has displayed cytotoxicity against ATC cell lines and has had a positive effect on ATC in a patient. Sodium iodide symporter (NIS) genetherapy is also being currently considered for dedifferentiated thyroid carcinomas with the ultimate aim of making radioiodine therapy possible.

Research paper thumbnail of Isolation and structural characterization of thymosin-β4 from a human medullary thyroid carcinoma

Journal of Endocrinology, Jul 1, 1988

ABSTRACT An extract of a tumour metastases from a human medullary thyroid carcinoma contained a h... more ABSTRACT An extract of a tumour metastases from a human medullary thyroid carcinoma contained a high concentration (at least 2·9 nmol/g wet weight) of the immunoregulatory peptide, thymosin-β4. The peptide was isolated as a mixture of two components with free and blocked NH2-terminal amino acid residues, the latter form predominating (approximately 98% of the total). The primary structure of the peptide was established by automated Edman degradation after cleavage with cyanogen bromide. The amino acid sequence of human thymosin-β4 was identical to thymosin-β4 previously isolated from calf thymus. Further studies are warranted to determine whether thymosin-β4 production is a useful marker for thyroid and other tumours. J. Endocr. (1988) 118, 155–159

Research paper thumbnail of Tratamiento del cáncer anaplásico de tiroides

Revisiones en cáncer, 2005

Los carcinomas anaplasicos de tiroides (CAT) estan entre los canceres mas agresivos, con una medi... more Los carcinomas anaplasicos de tiroides (CAT) estan entre los canceres mas agresivos, con una mediana de supervivencia de 3-6 meses. Antiguamente, la muerte por CAT solia deberse al crecimiento local y producirse, fundamentalmente, por asifixia. Debe hacerse todo lo posible por controlar el tumor primario, mejorando asi la calidad del resto de la vida. Desde hace 30 anos se han venido usando distintos tratamientos combinados, incluidos la radioterapia, los farmacos citostaticos y la cirugia, en los casos factibles. En nuestro ultimo regimen combinado, 22 pacientes se trataron con radioterapia hiperfraccionada a dosis de 1,6 Gy x 2, hasta una dosis objetivo total de 46 Gy, en el preoperatorio, 20 mg de doxorrubicina administrados por la via intravenosa semanalmente y cirugia a las 2-3 semanas de haber finalizado la radioterapia. Se opero a diecisiete de estos 22 pacientes, no presentando recurrencias locales ninguno de los 17. El reto futuro es el tratamiento de las metastasis a distancia. Se recomiendan los nuevos agentes quimioterapeuticos y las nuevas modalidades, como los inhibidores de la angiogenesis.

Research paper thumbnail of Thyroid and Parathyroid Carcinoma

Springer eBooks, 1989

Malignant neoplasms of the thyroid are rare and account for about 1% of all cancers. About 90% of... more Malignant neoplasms of the thyroid are rare and account for about 1% of all cancers. About 90% of the thyroid malignancies are differentiated carcinomas including papillary, follicular and medullary tumours. Differentiated thyroid carcinomas often appear in young individuals and have a peak incidence in the third or fourth decade. In contrast, the anaplastic thyroid carcinoma is largely a disease of the elderly.

Research paper thumbnail of Dual energy 4D-CT of parathyroid adenomas not clearly localized by sestamibi scintigraphy and ultrasonography – a retrospective study

European Journal of Radiology, Mar 1, 2020

This is a PDF file of an article that has undergone enhancements after acceptance, such as the ad... more This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Research paper thumbnail of Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas

European journal of endocrinology, Jun 1, 2000

Research paper thumbnail of Effect of the SARS-CoV-2 pandemic on planned and emergency hernia repair in Sweden: a register-based study

Hernia, Jul 7, 2023

Purpose The COVID-19 has had a profound impact on the health care delivery in Sweden, including d... more Purpose The COVID-19 has had a profound impact on the health care delivery in Sweden, including deprioritization of benign surgeries during the COVID-19 pandemic. The aim of this study was to assess the effect of COVID-19 pandemic on emergency and planned hernia repair in Sweden.